2. Attention-Deficit Hyperactivity
Disorder, Early Detection
Prof. Hani Hamed Dessoki, M.D.PsychiatryProf. Hani Hamed Dessoki, M.D.Psychiatry
Prof. PsychiatryProf. Psychiatry
Chairman of Psychiatry DepartmentChairman of Psychiatry Department
Beni Suef UniversityBeni Suef University
APA memberAPA member
3. DisclosureDisclosure
• NO relevant financial relationships with aNO relevant financial relationships with a
commercial interest.commercial interest.
4. Outline of Presentation
I. History of ADHD
II. Diagnosis and Associative Features
III. Statistics
IV. Etiology
A. Environmental Theories
B. Biogenic Theories
V. Prognosis and Impact
VI. Treatment
5. Attention Deficit Hyperactivity
Disorder (ADHD(
ADHD is a pervasive, heterogeneous
behavioural syndrome characterised by
the core symptoms of inattention,
hyperactivity and impulsivity.
6. ADHD: Historical Development of the Concept
1902: George Still identified impulse control difficulties in some children
1950s: Medical model explanations predominated: “minimal brain damage”,
and “educationally subnormal” labels were used
1970s: Psychological/Familial/Environmental models gained ground:
individual and family coping strategies were emphasised
1980s: In the USA, “Attention Deficit Disorder” had been added to DSMIII
1990s: Concept of “Attention Deficit” and ADHD gained ground in the U.K.
In the U.S., DSMIV added “hyperactivity” to the main diagnosis and
ADD became one of the sub-categories.
8. Diagnosing ADHD
• Clinical examinations and questionnaires are important because of the
many controversial diagnosis of ADHD (Jackson & Farrugia, 1997(
• Medical and family history
– physical examination
– interviews with parents, the child, and child’s teacher
– behavior rating scales by parents and teacher
– observation of the child
– psychological tests (IQ, social and emotional adjustment, and
indication of learning disabilities(
• DSM-IV (1994( allows for adult diagnosis as long as the associative
characteristics are met...
9. Attention-Deficit
Hyperactivity Disorder
(ADHD( – DSM IV definition
Attention-Deficit Hyperactivity Disorder (ADHD)
is a neurobiological condition that characterized
by developmentally inappropriate level of
inattention (concentration, distractibility)
hyperactivity and impulsiveness that can occur
in various combinations across school, home,
and social settings.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision. Washington, DC, American Psychiatric Association, 2000.
15. Statistics
• Effects 3-5% of all school-aged children
• Most commonly diagnosed behavioral disorder in children
• 9-18% of school-aged children with mental retardation meet criteria for
ADHD (comorbidity is high in ADHD( (Epstein et al, 1986(
• Males to female ratio ranges from 4:1 to 9:1 depending on the setting (clinic
or general population( (DSM-IV, 1994(
16. Statistics
• Occurs in all cultures, with prevalent findings in Western cultures (due to
diagnostic methods( (DSM-IV(
• Mood and Anxiety, Learning, Substance-related, and Antisocial Personality
Disorders are more prevalent in family members of those with ADHD (high
rate of comorbidity( (DSM-IV(
• 9.5 million adults are suffering from ADHD (Quinn, 1997(
17. Why the Explosion in ADHD?
- Possible Explanations
1. We are better at finding and helping
children and adults who really do have
ADHD.
2.There are more children now who actually
have ADHD
18. Why the Explosion in ADHD?
- Possible Explanations
3.We have loosened the definition so more
kids are being diagnosed and treated.
4.We are actually diagnosing and treating
many children who don’t have ADHD, even
by a loosened definition.
20. Aetiology
• Heritability is the strongest factor in
development of ADHD
• Risk factors account for only a small portion of
variance
• Pregnancy variables: young maternal age,
maternal use of tobacco and alcohol, toxaemia,
post-maturity and extended labour
• Medical factors: fragile X syndrome, G6PD
deficiency, phenylketonuria, brain trauma, lead
poisoning, malnutrition
21. Main Neurotransmitters in ADHD
• Dopamine
• Noradrenaline
To regulate the inhibitory influences in
the frontal-cortical processing of
information
25. Associate symptoms with brain regions and
circuits that regulate them
HyperactiveHyperactive
symptomssymptoms
ImpulsiveImpulsive
symptomssymptoms
PrefrontalPrefrontal
motormotor
cortexcortex
OrbitalOrbital
frontalfrontal
cortexcortex
SelectiveSelective
attentionattention
SustainedSustained
attentionattention
problemproblem
solvingsolving
DorsalDorsal
ACCACC
DLPFCDLPFC
Stahl , 2008
26. Match neurotransmitters with circuits
DorsalDorsal
ACCACC
DLPFCDLPFC
HAHA
NENE DADA
AChACh
Selective attentionSelective attention Sustained attentionSustained attention
problem solvingproblem solving
•Little attention to detailLittle attention to detail
•Careless mistakesCareless mistakes
•Does not listenDoes not listen
•Loses thingsLoses things
•DistractedDistracted
•forgetfulforgetful
•Sustaining attentionSustaining attention
•follow through/finishfollow through/finish
•OrganizingOrganizing
•Avoids sustainedAvoids sustained
mental effortmental effortStahl , 2008
27. Aetiology
• ADHD symptoms and a diagnosis of ADHD may
themselves create interpersonal problems and
produce additional symptoms in the child
• Some children sensitive to
colourings/preservatives – not sugar per se
28. - Neurophysiological Factors:
Studies using PET have found lower cerebral blood flow
and metabolic rates in the frontal lobe areas of
children with ADHD than controls, pointing towards
frontal-striatal dysfunction.
- Psychosocial Factors:
Stressful psychic events, disruption of family
equilibrium and other anxiety provoking factors
contribute to the initiation or perpetuation of ADHD.
Etiology of ADHD
30. Inattention symptoms
• Fails to give close attention; careless mistakes
• Difficulty sustaining attention in tasks or play activities = requires
frequent redirection
• Does not seem to listen when spoken to directly
• Does not follow through on instructions; fails to finish task (not
oppositional or failure to understand
• Difficulty organizing tasks = homework poorly organized
• Dislikes sustained mental effort = schoolwork; homework
• Loses possessions
• Easily distracted
• Forgetful
31. Hyperactivity
• Fidgets
• Leaves seat when expected to sit
• Runs or climbs excessively
• Difficulty in playing quietly
• Often "on the go" or acts as if "driven by a motor"
• Often talks excessively
Perceived « immature »
Accidents/injuries prone
32. Impulsivity
• blurts out answers before questions
completed
• difficulty waiting turn
• interrupts or intrudes on others
Impatient
Rushing into things
Risk taking; Taking dares
33. DSM IV Criteria
A:
• 6 / 9 inattention
&/or
• 6 / 9 hyperactivity & impulsivity
= 6 months; maladaptive & inconsistent with development level
B: symptoms before age of 7
C: impairment in 2 settings
D: clinically significant – social/academic
E: not better explained by something else
34. A) Six or more of the following symptoms of inattention have been present for
at least 6 months to a point that is disruptive and inappropriate for
developmental level:
Inattention (CALL FOR FRED)
1) Often does not give close attention to details or makes Careless
mistakes in schoolwork, work, or other activities.
2) Often has trouble keeping Attention on tasks or play Activities.
3) Often does not seem to Listen when spoken to directly.
4) Often does not Follow instructions and Fails to finish schoolwork,
chores, or duties in the workplace (not due to oppositional behavior
or failure to understand instructions).
5) Often has trouble Organizing activities.
6) Often avoids, dislikes, or doesn’t want to do things that take a lot of
mental effort for a long period of time (such as schoolwork or
homework). Reluctant
7) Often Loses things needed for tasks and activities
(e.g. toys, school assignments, pencils, books, or tools).
8) Is often easily Distracted.
9) Is often Forgetful in daily activities.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision. Washington, DC, American Psychiatric Association, 2000.
Attention-Deficit/Hyperactivity Disorder
--Diagnostic Criteria
35. B) Six or more of the following symptoms of hyperactivity-impulsivity have
been present for at least 6 months to an extent that is disruptive and
inappropriate for developmental level:
Hyperactivity (RUNS FASTT)
1) Often fidgets with hands or feet or squirms in seat.
2) Often gets up from seat when remaining in seat is expected.
3) Often runs about or climbs when and where it is not appropriate
(adolescents or adults may feel very restless).
4) Often has trouble playing or enjoying leisure activities quietly.
5) Is often "on the go" or often acts as if "driven by a motor".
6) Often talks excessively.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision. Washington, DC, American Psychiatric Association, 2000.
Attention-Deficit/Hyperactivity Disorder
--Diagnostic Criteria
36. Impulsivity
7) Often blurts out answers before questions have been
finished.
8) Often has trouble waiting one’s turn.
9) Often interrupts or intrudes on others (e.g., butts into
conversations or games).
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision. Washington, DC, American Psychiatric Association, 2000.
Attention-Deficit/Hyperactivity Disorder
--Diagnostic Criteria
37. Based on these criteria, three types of ADHD are identified:
1) ADHD, Combined Type: if both criteria 1A and 1B are met for
the past 6 months.
2) ADHD, Predominantly Inattentive Type: if criterion 1A is met
but criterion 1B is not met for the past six months.
3) ADHD, Predominantly Hyperactive-Impulsive Type: if
Criterion 1B is met but Criterion 1A is not met for the past six
months.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision.
Washington, DC, American Psychiatric Association, 2000.
Attention-Deficit/Hyperactivity Disorder
--Diagnostic Criteria
38. Depending upon which symptoms predominate
DSM-IV-TR
recognized three subtypes of ADHD.
Combined subtype - 50% to 75%
Inattentive subtype - 20% to 30%
Hyperactive impulsive subtype - <15% cases
Subtypes of ADHD
39. 1.Infancy:
- More active, sleep less and cry much.
- Difficult to recognize until child achieves toddler age.
2.Preschool
- Motor restlessness, insatiable curiosity, vigorous and
destructive play ,demanding of parental attention
- Excessive temper tantrums.
- Decrease and/or restless sleep.
- Delays in motor and language development.
Clinical Features
41. 3.School age Children:
- Easily distracted.
- Difficulty in waiting for a turn.
- At home cannot be put off for even a minute.
- Often irritable.
- Emotionally labile – easily set off to laughter and tears.
- Mood and performance is variable and unpredictable.
- Impulsive- unable to delay gratification.
- Accident prone.
- Negative self concept and reactive hostility.
- 75% children show behavioral symptoms of aggression
and defiance.
- School difficulties both learning and behavioral coexist.
Clinical Features (cont…)
42. Scope of problem: school and
adolescence
• At least 10% of children under 18 years of age are or have
been affected by psychiatric disorders (12% of boys, 8% of
girls) - including ADHD, ASD, TS, CD, (and psychosis,
eating disorder, depression, and anxiety disorders)
• Another 10% or more are affected by various kinds of
psychosocial problems (including drug abuse), some of
which may be triggered by or interacting with ESSENCE
• About 5% are affected by “dyslexia”
• 1-2% are affected by LD
• Overlap/”Comorbidity”/Co-existence substantial
• When looking back: vast majority had symptoms <5 years
43. 4.Adolescents:
- Excessive motor activity.
- Discipline problems, family conflicts.
- Anger and emotional liability.
- Difficulty with authority.
- Significant lags in academic performance.
- Poor peer relationship.
- Poor self esteem.
- Speedy accidents.
- Delinquent children.
Clinical Features (cont…)
44. 5.Adults:
- Difficulty with concentration and performing
sedentary tasks.
- Disorganization.
- Forgetfulness.
- Failure to plan.
- Depending on others to maintain order.
- Trouble both getting started and ending tasks.
- Changing plans and jobs in midstream.
- Restlessness , impulsivity.
- Absent mindedness.
- Anti social acts.
Clinical Features (cont…)
45. Significance of InattentionSignificance of Inattention
for cognitive processesfor cognitive processes
Chhabildas, Pennington, Willcutt, J Abnorm Child Psychol, 2001Chhabildas, Pennington, Willcutt, J Abnorm Child Psychol, 2001
• Inattention symptom cluster is theInattention symptom cluster is the
strongest predictor of neuropsychologicalstrongest predictor of neuropsychological
impairmentsimpairments
– vigilance, processing speed, inhibitionvigilance, processing speed, inhibition
• Hyperactivity/impulsivityHyperactivity/impulsivity notnot associatedassociated
with neuropsychological impairmentswith neuropsychological impairments
46. Expert Rev Neurother , 2011
• Early detection and intervention may
prevent or ameliorate the development of
the disorder and reduce its long-term
impact.
47. DD
• Age appropriate behaviors in active
children,
• Intelligent children in under stimulating
environments eg classrooms,
• MR
• Psychiatric: ODD,CD, Anxiety disorders,
substance use disorders, PTSD, Mood
dis, PDD, LD
• Psychosocial: abuse/ neglect; poor
nutrition, chaotic family, bullied at school,
violent neighborhood
• Medical: Thyroid, heavy metal poisoning,
medications: sedating or activating
48. As many as one-third of
children diagnosed with
ADHD also have a co-
existing condition
49.
50. Comorbid DSM-IV Disorders
• Oppositional Defiant Disorder (40-70%)
ADHD contributes to and likely causes ODD.
• Conduct Disorder (20-56%)
• Delinquent/Antisocial Activities (18-30%)
Psychopathy – rates unknown but 20% of CD.
• Anxiety Disorders (10-40%; referral bias!)
Related to poor emotion regulation than to fear.
• Major Depression (0-45%; 27% by age 20)
Likely genetic linkage to ADHD.
• Bipolar Disorder (0-27%; likely 6-10% max.)
Not documented in any follow-up studies to date.
52. Oppositional Defiant Disorder
(ODD)
A pattern of negativistic, hostile and defiant behavior
lasting at least six months, during which four or
more of the following are present:
• Often loses temper.
• Often argues with adults.
• Often actively defies or refuses to follow adults rules.
• Often deliberately annoys people.
• Often blames others for his/her mistakes.
• Often is touchy / easily annoyed by others.
• Often is resentful.
• Often is spiteful / vindictive.
The disturbance in behavior causes significant impairment in social,
academic or occupational functioning.
53. Conduct Disorder
Repetitive and persistent pattern of behavior in
which the basic rights of others or major age
appropriate norms or rules of society are
violated.
• Aggression to people or animals.
• Destruction of property.
• Deceitfulness or theft.
• Serious violation of rules.
55. Prognosis
• 50% continue to suffer from clinically
significant symptoms
• Increased risk for substance use disorders
particularly if CD
• Low self esteem and poor social skills
56. Essential Concepts
• ADHD is a clinical diagnosis based on:
– Careful history taking
– Clinical examination
– Information from several sources & multiple settings (school, home& community)
• Hyperactivity does not need to be present during the mental state
exam to diagnose ADHD
• Concomitant learning disabilities & comorbid psychiatric disorders should
be evaluated
• Morbidity & disability often persist into adult life
• Children with ADHD have a higher injury rates, increased rate for CD
(1/3), criminal behavior, substance abuse, coordination deficits & other
psychiatric disorder (over 50%)
• There is increased risk for physical punishment, stress within the family
and economic cost to schools and criminal justice
57. ADHD Guideline Recommendations
1. The primary care clinician should initiate an
evaluation for ADHD for any child who
presents with academic or behavioral
problems and symptoms of inattention,
hyperactivity, or impulsivity. B/strong
recommendation
American Academy of Pediatrics
58. ADHD Guideline Recommendations
2. To make a diagnosis of ADHD, the primary
care clinician should determine that Diagnostic
and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) criteria have been met
(including documentation of impairment in
more than 1 major setting) with information
obtained primarily from parents/guardians,
teachers, and other school and mental health
clinicians involved in the child’s care. The
primary care clinician should also rule out any
alternative cause. B/strong recommendation
American Academy of Pediatrics
59. ADHD Guideline Recommendations
3. Evaluation of a child for ADHD should include
assessment for coexisting conditions, including
emotional, developmental, and physical.
B/strong recommendation
60. ADHD Guideline Recommendations
4. The primary care clinician should establish a
treatment program that recognizes ADHD as a
chronic condition and a child with ADHD as a
child/adolescent with special health care needs
who needs a medical home. B/strong
recommendation
61. Evaluation
Identify core symptoms.
Assess impairment.
Identify possible underlying or alternative
causes.
Identify co-occurring (co-morbid) conditions.
62. Assessment
• History – parents or caregivers,
− as well as a classroom teacher or other
school professional
• Interview of child
• Parent and teacher ratings of ADHD-related
behaviours
• Investigations - No clinical examination or lab tests
are accepted as either “rule in” or “rule out.”
Recommend vision & hearing tested
63. Overlap and issues
• Is ODD not a comorbidity but an index of
severity in ADHD?
• Are learning problems a result of non-assortative
mating in parents?
• Are DCD problems an index of a link with ASD?
• Is ASD a very common comorbidity signalling
some shared genes?
• Are ASD and ADHD in some cases on the same
spectrum?
64. Impact
Emotional
• Low self esteem
• Impaired self-regulation
• Relationship difficulties
Cognitive
• Organizing; planning and time management
• Learning delay
• Short term memory problems; lack of focus
• Language/speech
Physical
• Fine & gross motor skill delay
Behaviour
• Impaired self-regulation
67. Non-Pharmacological
Management
Diet
• Elimination diets – difficult
• Omega 3 – at least 1000mg/day for a month
Academic skills training: focus on following
directions, becoming organized, using time
effectively, checking work, taking notes
68. Non-Pharmacological Management
Behavioural therapy
- Does not reduce symptoms
– May improve social skills and compliance
– Does not lead to maintenance of gains or
improvement over time after the therapy is
completed
Social skills group
- Uses modelling, practice, feedback and
contingent reinforcement to address the social
deficits common in children with ADHD
- Useful for the secondary effects of ADHD,
such as low self-esteem, but not helpful for
core symptoms of ADHD
69.
70.
71. MEDICATIONS FOR ADHD
Stimulant Medications
–Methylphenidate (Ritalin, Ritalin
LA, Concerta)
–Dexamphetamine
Non-stimulant
Atomoxetine (Strattera)
Other
Clonidine (Catapres)
Risperidone (Risperdal)
72. MEDICATIONS FOR ADHD
Tricyclic Antidepressants
–Desipramine ;Imipramine (Tofranil)
Other Antidepressants
–Bupropion (Zyban); Fluoxetine
(Prozac)
73. Stimulants Specific Effects
• Improved sustained attention
• Reduced distractibility
• Improved short-term memory
• Reduced impulsivity
• Reduced motor activity
• Decreased excessive talking
• Reduced bossiness and aggression
with peers
74. Non-Stimulants
Atomoxetine is a highly specific norepinephrine
reuptake inhibitor.
Extended release guanfacine and clonidine are
alpha 2 adrenergic agents.
75. ADHD Guideline Recommendations
5. Recommendations for treatment of children
and youth with ADHD vary depending on the
patient’s age:
76. Preschool-aged Children
(4–5 Years of Age(
A. Prescribe evidence-based parent- and/or
teacher-administered behavior therapy as the
first line of treatment. A/strong
recommendation
and
May prescribe methylphenidate if the behavior
interventions do not provide significant
improvement and there is moderate-to-severe
continuing disturbance in the child’s function.
B/recommendation
77. Elementary School-aged Children
(6–11 Years of Age(
B. Prescribe FDA-approved medications for
ADHD. A/strong recommendation
and/or
Evidence-based parent- and/or teacher-
administered behavior therapy as treatment for
ADHD.
Preferably both. B/recommendation
78. Adolescents (12–18 Years of Age(
C. Prescribe FDA-approved medications for
ADHD with the assent of the adolescent.
A/strong recommendation
and
May prescribe behavior therapy as treatment for
ADHD. C/recommendation
Preferably both.
79. ADHD Guideline Recommendations
6. The primary care clinician should titrate doses
of medication for ADHD to achieve maximum
benefit with minimum adverse effects. B/strong
recommendation
80. How ADHD affects children or adolescents and their families.
Potential benefits associated with nonpharmacologic interventions
such as parental behavior therapy programs.
Potential benefits and adverse effects associated with
psychostimulants and nonstimulants.
Patient preferences regarding diagnosis and treatment options,
including pharmacologic and nonpharmacologic interventions.
How they can access information on ADHD about diagnosis and
treatment, educational programs, public benefits, and other issues.
What To Discuss With Your Patients
and Their Caregivers
Charach A, Dashti B, Carson P, et al. AHRQ Comparative Effectiveness Review No. 44. October 2011. Available at
www.effectivehealthcare.ahrq.gov/adhdtreatment.cfm.
81. Summary
Children from preschool age through
adolescent age can be diagnosed and treated
for ADHD.
Both medications (stimulants, selective
norepinephrine reuptake inhibitors and alpha
adreneric agents) and behavior therapy are
effective and safe treatments for ADHD.
Effective treatments require appropriate
titration and ongoing monitoring to remain
effective.
82. Effective Treatment of ADHD
Multidisciplin
e:
– Medical
– Psychological
– Educational
– Rehabilitation
The Team :
1.Consultant Child and Adolescent Psychiatrist
2.Clinical Psychologists
3.Occupational Therapists
4.Speech Therapists
5. Parents & Family
6. School officials
Hinweis der Redaktion
One of our most deeply held cultural values is that a child’s behavior is a reflection of how they were raised. It is a belief so deep that it is nearly instinctual. Example: Imagine yourself on the cereal aisle of the grocery store. A child is having a massive screaming, crying, kicking tantrum as he clutches a box of chocolate cocoa puffs. Now, how many of you, in your heart of hearts, have witnessed such a seen and have thought, “What a brat. Why doesn’t she do something.” Even though I know better, and even though I’ve heard countless moms of ADHD children tell me about having to abandon a half-full grocery cart, the thought still occurs to me. So, if a child is unruly, willful, a social misfit or a school drop-out, the parent must be to blame, particularly the mother. Psychiatric disorders in children have been variously attributed to lazy and inconsistent parenting, mothers working outside the home and divorce. The same sort of moral judgements are ascribed to affected children as well.. The commonly heard phrase, “He could do it if he wanted to”, sort of sums it all up. Here’s what we know. Kids with ADHD are difficult to parent, but their symptoms are not the result of inadequate parenting, or of even divorce or working outside the home. Denying the existence of psychiatric disorders in children is a reflection of the enormous stigma attached to mental illness.
The proponents of this idea view ADHD as a malignant social construct. ADHD is viewed as a social metaphor for our frenetic, competitive, conveyor belt of world. Tx therefore isn&apos;t about ameliorating impairment; it&apos;s about performance enhancement. It&apos;s about ambitious parents cultivating any advantage at the expense of medicating their children. It&apos;s about teachers and parents who want kids drugged and docile. It&apos;s about everyone and their brother looking for an excuse or an easy way out. These concerns are both true and false. There is evidence that the diagnosis of ADHD and it treatments have been misapplied. Most of the evidence is anecdotal; a physician named Lawrence Diller wrote an entire book about his clinical experiences entitled, &quot;Running on Ritalin&quot;. Alot of people point to the dramatic increase in office visits for ADHD and the accompanying prescription of stimulants following the inclusion of ADHD under the IDEA in 1991 as evidence of this social phenomena. Some people view the same &quot;Ritalin Explosion&quot; as indicative of rampant illicit use of stimulants. The reality is that many factors have contributed to increased prescribing of stimulants, which I will review in just a bit. There have been a few studies looking at regional prescribing practices
That is, if ADHD really existed, there would be an objective physical finding. The subjective nature of the diagnostic process in and off itself suggests that the disorder is an artificial construct or made up.
“where were these people when I was growing up?”
The pervasive sense that “we” in pediatrics and MH don’t really know what we are doing is fueled by reports of misdiagnosis, and particularly, overdiagnosis.
More controversy. I’d like to present a brief overview of the medical treatments of ADHD before discussing these myths.
Understanding what these medications are and how they work goes a long way in disabusing people of the notion that they are dangerous and addictive. It also provides a context for a discussion of the risk vs. the benefit of taking medication. Every medication - including any medication or herbal remedy you can purchase over the counter - presents a risk of side effects. The question is, what is the risk of not taking a medication, and do the negative effects outweigh the positive.
Atomoxetine has a high selectivity and affinity for the norepinephrine transporter.
It has little or no activity on other neurotransmitters.
The low affinity for other neuronal transmitters indicates a low potential for side effects associated with activity at these receptors.
References:
Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 2001;108:E83. Available from: URL: http://www.pediatrics.org/cgi/content/full/108/5/e83.
Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone SV, Rea J, Witcher J, Zervas S. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.J Child Adolesc Psychopharmacol 2001;11:251-265.
Kratochvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2001;11:167-170.
What To Discuss With Your Patients and Their Caregivers
Things you should discuss with your patients and their caregivers regarding ADHD in children include:
How ADHD affects children and their families.
Potential benefits associated with nonpharmacologic interventions such as parental behavior therapy programs.
Potential benefits and adverse effects associated with psychostimulants and nonstimulants. In choosing medications, it is useful to discuss dose timing and monitoring to make choices most compatible with treatment goals and patient schedules and lifestyle.
Patient preferences regarding diagnosis and treatment options, including pharmacologic and nonpharmacologic interventions.
How they can access information from the National Resource Center on ADHD about diagnosis and treatment, educational programs, public benefits, and other issues. The Center is supported with funding from the Federal Government through the Centers for Disease Control and Prevention (CDC). ADHD information can be accessed online at www.help4adhd.org or by phone at 800-233-4050.
Reference:
Charach A, Dashti B, Carson P, et al. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment. Comparative Effectiveness Review No. 44 (Prepared by McMaster University Evidence-based Practice Center under Contract No. MME 2202 290-02-0020). Rockville, MD: Agency for Healthcare Research and Quality; October 2011. AHRQ Publication No. 11(12)-EHC003-EF. Available at www.effectivehealthcare.ahrq.gov/adhdtreatment.cfm.